1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

André Faldt (Opfinder), Heidi Lopez De Diego (Opfinder), Rene Holm (Opfinder)

Publikation: Patent

Abstrakt

1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

OriginalsprogEngelsk
IPCC07D 295/ 096 A I
PatentnummerUS2017360777
Land/OmrådeDanmark
Prioritetsdato10/08/2017
PrioritetsnummerUS201715674043
StatusUdgivet - 21. dec. 2017
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om '1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'. Sammen danner de et unikt fingeraftryk.

Citationsformater